Drägerwerk KGaA Past Earnings Performance
Past criteria checks 3/6
Drägerwerk KGaA's earnings have been declining at an average annual rate of -10.1%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 2.2% per year. Drägerwerk KGaA's return on equity is 8%, and it has net margins of 3.4%.
Key information
-10.1%
Earnings growth rate
-11.3%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 2.2% |
| Return on equity | 8.0% |
| Net Margin | 3.4% |
| Next Earnings Update | 03 Apr 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Drägerwerk KGaA makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 3,348 | 113 | 983 | 328 |
| 30 Jun 24 | 3,362 | 116 | 983 | 324 |
| 31 Mar 24 | 3,348 | 100 | 968 | 323 |
| 31 Dec 23 | 3,374 | 110 | 963 | 325 |
| 30 Sep 23 | 3,339 | 94 | 965 | 339 |
| 30 Jun 23 | 3,275 | 41 | 973 | 343 |
| 31 Mar 23 | 3,157 | -21 | 983 | 345 |
| 31 Dec 22 | 3,045 | -65 | 981 | 343 |
| 30 Sep 22 | 2,953 | -149 | 982 | 351 |
| 30 Jun 22 | 2,997 | -83 | 968 | 347 |
| 31 Mar 22 | 3,186 | 25 | 958 | 339 |
| 31 Dec 21 | 3,328 | 134 | 938 | 329 |
| 30 Sep 21 | 3,518 | 224 | 945 | 311 |
| 30 Jun 21 | 3,611 | 274 | 930 | 298 |
| 31 Mar 21 | 3,558 | 278 | 909 | 294 |
| 31 Dec 20 | 3,406 | 189 | 912 | 290 |
| 30 Sep 20 | 3,173 | 171 | 877 | 278 |
| 30 Jun 20 | 2,973 | 94 | 869 | 275 |
| 31 Mar 20 | 2,819 | 29 | 861 | 268 |
| 31 Dec 19 | 2,781 | 25 | 848 | 264 |
| 30 Sep 19 | 2,765 | 48 | 827 | 255 |
| 30 Jun 19 | 2,715 | 39 | 816 | 253 |
| 31 Mar 19 | 2,701 | 44 | 814 | 253 |
| 31 Dec 18 | 2,595 | 26 | 797 | 252 |
| 30 Sep 18 | 2,564 | 16 | 795 | 255 |
| 30 Jun 18 | 2,572 | 37 | 791 | 251 |
| 31 Mar 18 | 2,533 | 46 | 770 | 241 |
| 31 Dec 17 | 2,572 | 74 | 770 | 235 |
| 30 Sep 17 | 2,556 | 73 | 769 | 227 |
| 30 Jun 17 | 2,528 | 70 | 767 | 221 |
| 31 Mar 17 | 2,526 | 74 | 765 | 221 |
| 31 Dec 16 | 2,524 | 61 | 768 | 219 |
| 30 Sep 16 | 2,530 | 48 | 812 | 220 |
| 30 Jun 16 | 2,541 | 17 | 831 | 226 |
| 31 Mar 16 | 2,596 | 15 | 856 | 229 |
| 31 Dec 15 | 2,609 | 25 | 868 | 231 |
| 30 Sep 15 | 2,553 | 46 | 818 | 232 |
| 30 Jun 15 | 2,541 | 90 | 797 | 223 |
| 31 Mar 15 | 2,467 | 85 | 775 | 218 |
| 31 Dec 14 | 2,435 | 97 | 750 | 212 |
| 30 Sep 14 | 2,383 | 94 | 742 | 206 |
| 30 Jun 14 | 2,347 | 85 | 732 | 205 |
| 31 Mar 14 | 2,354 | 101 | 733 | 203 |
| 31 Dec 13 | 2,374 | 115 | 745 | 202 |
Quality Earnings: DRW3 has high quality earnings.
Growing Profit Margin: DRW3's current net profit margins (3.4%) are higher than last year (2.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DRW3's earnings have declined by 10.1% per year over the past 5 years.
Accelerating Growth: DRW3's earnings growth over the past year (21%) exceeds its 5-year average (-10.1% per year).
Earnings vs Industry: DRW3 earnings growth over the past year (21%) did not outperform the Medical Equipment industry 21%.
Return on Equity
High ROE: DRW3's Return on Equity (8%) is considered low.